AOTI, Inc. Awaits Medicare Review for Oxygen Therapy

AOTI, Inc. (GB:AOTI) has released an update.

AOTI, Inc. is set to benefit from a potential boost in business momentum as the Centers for Medicare and Medicaid Services reviews coverage for its Topical Oxygen Therapy. This therapy has shown impressive results in reducing hospitalizations and amputations in patients with chronic wounds, and if approved, it could expand access to Medicare’s 65 million beneficiaries. AOTI’s innovative treatment could revolutionize chronic wound care, offering significant improvements in patient access and outcomes.

For further insights into GB:AOTI stock, check out TipRanks’ Stock Analysis page.